Literature DB >> 29952722

DDR1 and DDR2 in skin.

Muriel Cario1.   

Abstract

DDR1 and DDR2 are expressed in skin but their expression differs according to the skin compartment, epidermis, dermis, hypodermis and to the embryonic origin of the cells. In skin, it seems that during physiological processes such as wound healing or pathological processes such as tumorigenesis or systemic sclerosis development only one of the DDR is dysregulated. Furthermore, the altered DDR in pathological process is not necessarily the DDR implicated in basal homeostasis. Indeed, in epidermis, while DDR1 is the main DDR involved in melanocyte homeostasis, DDR2 seems to be the main DDR implicated in melanoma. On the contrary, in dermis, while DDR2 is necessary for normal wound healing, dysregulation of DDR1 is associated with abnormal wound healing leading to keloid. In conclusion, targeting DDR could be a therapeutic solution, however side effects have to be managed carefully.

Entities:  

Keywords:  CCN3; Melanocyte; cadherin; cell adhesive proteins; fibroblast; integrins; keratinocyte

Mesh:

Substances:

Year:  2018        PMID: 29952722      PMCID: PMC6363048          DOI: 10.1080/19336918.2018.1485618

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  2 in total

1.  Progression of skin lesions in Warburg-Cinotti syndrome.

Authors:  Christopher A Ours; Leslie G Biesecker; Thomas N Darling
Journal:  JAAD Case Rep       Date:  2021-12-15

2.  Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.

Authors:  Marcel Deckert; Sophie Tartare-Deckert; Ilona Berestjuk; Margaux Lecacheur; Alexandrine Carminati; Serena Diazzi; Christopher Rovera; Virginie Prod'homme; Mickael Ohanna; Ana Popovic; Aude Mallavialle; Frédéric Larbret; Sabrina Pisano; Stéphane Audebert; Thierry Passeron; Cédric Gaggioli; Christophe A Girard
Journal:  EMBO Mol Med       Date:  2021-12-27       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.